Blockbuster drug
Novo Nordisk and D Young defend crucial patent for tablet form of semaglutide
The European Patent Office has upheld a patent owned by Novo Nordisk. The patent is one of several intellectual property rights related to the diabetes and weight loss drug semaglutide, which the Dani
...
20 October 2025 by Konstanze Richter